Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Ceftolozane Sulfate

    Client Email Product

    Ceftolozane Sulfate

    APIs // Active Pharmaceutical Ingredients

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    1
    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    1
    API REF. PRICE (USD / KG)

    0

    API Market Place

    8
    INTERMEDIATES
    1
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    1
    Europe

    Europe

    3
    Canada

    Canada

    1
    Australia

    Australia

    0

    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    8.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    4
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    28

    USFDA Exclusivities

    3
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    18
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)
    Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)

    https://professionals.optumrx.com/content/dam/optum3/professional-optumrx/news/rxnews/drug-recalls-shortages/drugshortage_zerbaxa_2021-0423.pdf

    PROFESSIONALS
    12 Oct 2021
    Share Share
    Enforcement Report - Week of January 13, 2021
    Enforcement Report - Week of January 13, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-13-2021-1610520934.pdf

    FDA
    13 Jan 2021
    Share Share
    Enforcement Report - Week of January 6, 2021
    Enforcement Report - Week of January 6, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-6-2021-1609918562.pdf

    FDA
    06 Jan 2021
    Share Share
    Health Canada Issues Recall Merck Canada Inc's Zerbaxa
    Health Canada Issues Recall Merck Canada Inc's Zerbaxa

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-merck-canada-incs-zerbaxa-1608715038.pdf

    HEALTH CANADA
    18 Dec 2020
    Share Share
    Ceftolozane/tazobactam: New treatment option for severe infections
    Ceftolozane/tazobactam: New treatment option for severe infections

    https://medicalxpress.com/news/2020-07-ceftolozanetazobactam-treatment-option-severe-infections.html

    MEDICALXPRESS
    02 Jul 2020
    Share Share
    EMA committee recommends approval of Merck's Zerbaxa 3g dose
    EMA committee recommends approval of Merck's Zerbaxa 3g dose

    http://www.pharmabiz.com/NewsDetails.aspx?aid=117266&sid=2

    PHARMABIZ
    31 Jul 2019
    Share Share
    Merck's new combo med Recarbrio fights resistant bacteria
    Merck's new combo med Recarbrio fights resistant bacteria

    https://www.fiercepharma.com/pharma/as-officials-grapple-antimicrobial-resistance-merck-scores-fda-approval-for-new

    Eric Sagonowsky FIERCE PHARMA
    17 Jul 2019
    Share Share
    Merck's treatment for urinary, abdominal infections gets FDA approval
    Merck's treatment for urinary, abdominal infections gets FDA approval

    https://in.reuters.com/article/us-merck-co-fda/mercks-treatment-for-urinary-abdominal-infections-gets-fda-approval-idINKCN1UC19W

    REUTERS
    17 Jul 2019
    Share Share
    Merck scores a new Zerbaxa indication
    Merck scores a new Zerbaxa indication

    https://www.fiercepharma.com/pharma/merck-scores-zerbaxa-label-expansion-years-after-cubist-buyout

    Eric Sagonowsky FIERCE PHARMA
    05 Jun 2019
    Share Share
    Results of Ph3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam)
    Results of Ph3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam)

    https://www.businesswire.com/news/home/20190413005021/en/Results-Phase-3-Trial-Evaluating-Merck%E2%80%99s-ZERBAXA%C2%AE/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    15 Apr 2019
    Share Share
    FDA accepts two of MSD’s new drug applications
    FDA accepts two of MSD’s new drug applications

    http://www.pharmatimes.com/news/fda_accepts_two_of_msds_new_drug_applications_1277462

    Anna Smith PHARMA TIMES
    06 Feb 2019
    Share Share
    Merck set to seek EU, US approval of Zerbaxa for pneumonia
    Merck set to seek EU, US approval of Zerbaxa for pneumonia

    https://www.firstwordpharma.com/node/1590308

    Matthew Dennis FIRST WORD PHARMA
    12 Sep 2018
    Share Share
    Merck heralds a rare Big Pharma success for antibiotic PhIII, but..
    Merck heralds a rare Big Pharma success for antibiotic PhIII, but..

    https://endpts.com/merck-heralds-a-rare-big-pharma-success-for-antibiotic-phiii-but-its-also-a-cautionary-tale-about-the-market/

    John Carroll ENDPTS
    11 Sep 2018
    Share Share
    Merck finally adds postsurgery med Bridion to US lineup.Will buyer step up?
    Merck finally adds postsurgery med Bridion to US lineup.Will buyer step up?

    http://www.fiercepharmamarketing.com/story/merck-finally-adds-post-surgery-med-bridion-its-us-lineup-will-hospital-buy/2015-12-16

    Tracy Staton FIERCE PHARMA MARKETING
    16 Dec 2015
    Share Share
    MSD debuts new antibiotic in the UK
    MSD debuts new antibiotic in the UK

    http://www.pharmatimes.com/Article/15-11-22/MSD_debuts_new_antibiotic_in_the_UK.aspx

    Selina Mckee Pharma Times
    22 Nov 2015
    Share Share
    FDA Drug Safety Communication: FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam)
    FDA Drug Safety Communication: FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam)

    http://www.fda.gov/Drugs/DrugSafety/ucm445919.htm

    Press Release FDA
    20 May 2015
    Share Share
    Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA™ (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases
    Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA™ (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases

    http://www.mercknewsroom.com/news-release/corporate-news/merck-announces-publication-pivotal-data-phase-3-clinical-studies-zerbax

    Press Release MERCK
    27 Apr 2015
    Share Share
    What Does Merck's $10B Buyback Plan Say About Pharma M&A?
    What Does Merck's $10B Buyback Plan Say About Pharma M&A?

    http://www.fiercepharma.com/story/what-does-mercks-10b-buyback-plan-say-about-pharma-ma/2015-03-26

    Tracy Staton FIERCE PHARMA
    27 Mar 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search